This Article is not live.
Legal Limbo: Genmab's Ofatumumab SPC Dilemma Heads To CJEU
Potter Clarkson
Contributor
Potter Clarkson is one of Europe’s leading full-service IP law firms. Our IP attorneys and solicitors maximise the value of our clients' innovation by providing the experience, vision and clarity required to create, protect, leverage and defend their ideas in the most commercial and strategic ways all over the world.
The Metropolitan Court of Hungary (Fővárosi Törvényszék) has referred a new question to the Court of Justice of the EU (CJEU) about the requirements for obtaining supplementary...
